Menu
Recruiting NCT05169762

Feminizing Treatment in Transgender Women and Non-binary Persons

— Observational Transgenderism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: standard treatment.
Who it may be relevant to
Registry conditions: Transgenderism. Basic parameters: from 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Denmark
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN

Overview

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Detailed description

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years,

Outcomes:

Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

Interventions

  • Other standard treatment
    starndard treatment for transgender women

Primary outcome measures

  • coronary plaque formation [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • assigned male at birth and eligeble for gender affirming feminizing treatment

Exclusion criteria

none

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Denmark · 1 center
  • OdenseUH — Odense

Identifiers

NCT: NCT05169762 · BICTX03

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗